19th November 2013, 10:00 (10.30) - 12.30 (followed by a light lunch), Royal College of Nursing, 20 Cavendish Square, London, W1G 0RN

At this event hosted by the Royal College of Nursing, ILC-UK launched a new report on adult immunisation. We also presented findings of major new research on adult immunisation across Europe which was published by the SAATI coalition in November 2013. The debate considered the findings of the research and explored how policymakers should respond to the challenges highlighted in the new reports.

According to the WHO, immunisation prevents between 2-3 million deaths a year across all age groups.[1]

Immunisation should be considered as a life course issue. It is generally the oldest and youngest in society who are the worst affected by vaccine preventable diseases. Increasing the uptake of vaccination across the life-course will help prevent the spread of disease to more vulnerable groups.

In an ageing society, it is important that adult immunisation attracts increasing attention from policy makers and health professionals.

  • In the EU, between 40,000 and 220,000 deaths per year can be attributed to influenza infection, depending on the pathogenicity of the circulating viral strain[2]. The highest prevalence occurs among older adults, especially those with chronic medical conditions or immunological disorders, resulting in increased mortality[3].
  • New evidence from Scotland suggests that the majority of cases of invasive pneumococcal infection are in older age groups: 41.1% (127 cases) were aged 65 years and older and 40.5% (125 cases) were aged 35 to 64 years, with just 18.4% (57 cases) being aged 34 and under.”[4]
  • Shingles affects approximately 250,000 adults in the UK every year.[5]

The SAATI (Supporting Active Ageing Through Immunisation) coalition is a voluntary pan-European partnership of individuals who have an interest in improving the health of citizens as they grow older, and reducing the incidence of illness through effective immunisation. In November 2013 they will publish a major research report on adult immunisation across Europe.

Following the research publication in Brussels, ILC-UK will launch a new report on adult immunisation which has been funded through an unrestricted educational grant from Pfizer International Operations. The report will inform UK policy makers to build on the success of childhood immunisation programmes to create a robust programme for adult immunisation. This event provides an opportunity to present and debate the latest research from SAATI and ILC-UK and consider the policy implications.

10:00 - 10:30
10:30 - 10:35
Welcome from Chair
10:35 - 12:25
Presentations from:
Helen Donovan (RCN)
Professor David Taylor (UCL)
Michael Corr (Immunisation Coordinator, Lewisham Healthcare NHS Trust)
David Sinclair (ILC-UK)
12:25 - 12:30
Close from Chair
12:30 - 13:00
Light lunch available


[2]European Centre for Disease Prevention and Control (ECDC). The hard facts are often overlooked: Influenza remains a threat.

[3]Influenza vaccines. Wkly Epidemiol. Rec.80,279–287 (2005). [Medline]

[4] HPS, weekly report 31 August 2011. Available at:

[5] See


View David Sinclair's presentation below: